国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
碘克沙醇和碘普罗胺对2型糖尿病患者肾功能影响的临床观察
Clinical Observation of the Effect of Iodixanol and Iopromide on Renal Function in Patients with Type 2 Diabetes Mellitus
  
DOI:
中文关键词:  造影剂  糖尿病  碘克沙醇  碘普罗胺
英文关键词:Contrast agent  Diabetes mellitus  Iodixanol  Iopromide
基金项目:
作者单位
李鸿波 刘波 刘敏 江汉大学附属医院 (武汉市第六医院)①放射科②心内科③综合科(武汉 430015) 
摘要点击次数: 1485
全文下载次数: 948
中文摘要:
      摘 要 目的:观察等渗造影剂(碘克沙醇)和低渗造影剂(碘普罗胺)对2 型糖尿病患者肾功能的影响。方法:拟行冠状动脉造影的糖尿病患者83 例随机分为碘克沙醇组与碘普罗胺组,所有患者于造影前1 d,造影后3 d、7 d检测血尿素氮(BUN)、血清肌酐(SCr)和尿微量白蛋白(mAlb)水平,比较两组的肾功能指标、造影剂肾病发生率和药品不良反应。结果:与造影前相比,碘普罗胺组造影后3 d的BUN、SCr和尿mAlb水平明显升高(P<0.05);造影后7 d,两组的BUN、SCr和尿mAlb水平与造影前无明显差异(P>0.05)。造影后3 d,碘克沙醇组的SCr、BUN以及尿mAlb水平均明显低于碘普罗胺组(P<0.05);碘克沙醇组药品不良反应及造影剂肾病的发生率均显著低于碘普罗胺组(P<0.05)。结论:与低渗造影剂碘普罗胺相比,糖尿病患者使用等渗造影剂碘克沙醇进行冠脉介入诊疗,造影剂肾病和其他药品不良反应发生率低,恢复周期较短,值得临床推广应用。
英文摘要:
      ABSTRACT Objective:To observe the effect on the renal function of type 2 diabetes patients by using isotonic contrast agent(iodixanol) and low permeability contrast agents(iopromide).Methods:83 cases of diabetic patients with coronary artery angiography were randomly divided into iodixanol and iopromide group.The blood urea nitrogen(BUN),serum creatinine(SCr) and urine micro albumin(mAlb) levels were detected in all patients at 1d before radiography,3d and 7d after angiography.The renal function indexes,incidence of contrast induced nephropathy and the adverse drug reaction were compared between the two groups. Results: Compared with before the contrast, the BUN,SCr and mAlb levels in the group of iopromide were significantly increased 3d after angiography(P<0.05); 7d after angiography, there was no significant difference in BUN,SCr and mAlb levels between the two groups(P>0.05). 3 days after coronary angiography, the SCr,BUN and mAlb level of the iodixanol group were significantly lower than that of the iopromide group(P<0.05); the incidence of adverse drug reactions and contrast induced nephropathy rate of the iodixanol group were significantly lower than those of the iopromide group(P<0.05).Conclusion:Compared with low osmolar contrast agent iopromide, using isotonic contrast medium iodixanol in patients with diabetes mellitus for coronary artery angiography, it had lower incidence of nephropathy, fewer adverse events shorter recovery period, worth a wide clinical application.
查看全文  查看/发表评论  下载PDF阅读器
关闭